Cardiovascular morbidity and mortality associated with the metabolic syndrome

Diabetes Care

Volumn 24, Issue 4, 2001, Pages 683-689

  Isomaa, Bo ^a   Almgren, Peter ^b   Tuomi, Tiinamaija ^c   Forsén, Björn ^d   Lahti, Kaj ^e   Nissén, Michael ^f   Taskinen, Marja Riitta ^c   Groop, Leif ^b  

^a Jakobstad Hospital   (Finland)

^b LUND UNIVERSITY   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Närpes Health Center   (Finland)

^e Vasa Health Care Center   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; STROKE;

EID: 0034837376     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.4.683     Document Type: Article

References (38)

1. Role of insulin resistance in human disease
2. Studien ueber des hypertonie-hyperglykämie-hyperurikämiesyndrom
3. Abdominal obesity and the metabolic syndrome
4. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus
5. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study
6. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
7. Das metabolische syndrom
8. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
9. An epidemic view of the plurimetabolic syndrome
10. Genetics of causes and manifestations of the metabolic syndrome
11. The deadly quartet: Upperbody obesity, glucose intolerance, hypertriglyceridemia, and hypertension
12. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance
13. Prospective analysis of the insulin-resistance syndrome (syndrome X)
14. Comments on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR)
15. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study
16. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects
17. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation
18. Metabolic consequences of a family history of NIDDM (the Botnia Study): Evidence for sex-specific parental effects
19. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
20. Characterisation of the MODY3 phenotype, early-onset diabetes caused by an insulin secretion defect
21. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
22. The homeostasis model in the San Antonio Heart Study
23. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifugation
24. Metabolic syndrome in a middle-aged Finnish population
25. Familial components of the multiple metabolic syndrome: The ARIC Study
26. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes
27. Glucose toxicity
28. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
29. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
30. New insights into lipid metabolism in non-insulin-dependent diabetes mellitus
31. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus
32. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population
33. Urinary albumin excretion and history of myocardial infarction in a cross-sectional study, of 2,613 individuals
34. Urinary albumin excretion: An independent predictor of ischemic heart disease
35. Hyperinsulinemic microalbuminuria: A new risk indicator for coronary heart disease
36. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature
37. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects